Skip to main content
. Author manuscript; available in PMC: 2023 Oct 10.
Published in final edited form as: Clin Infect Dis. 2021 Dec 6;73(11):e4321–e4328. doi: 10.1093/cid/ciaa1697

Table 2.

Symptom Predictors of Influenza Virus Infections Among Pregnant Women With Respiratory Illness: PRIME Cohort Study, 2017–2018

Influenza Positive (n = 310) Influenza Negative (n = 5134) P Final Model
n % n % aORa 95% CI P
Subjective fever 85 (27) 369 (7) <.0001*
Measured fever ≥38.0°C 55 (18) 131 (3) <.0001* 4.6 3.3, 6.8 <.0001*
Chills 50 (16) 353 (7) <.0001* 1.6 1.1, 2.3 .01*
Myalgias 206 (66) 2029 (40) <.0001* 2.9 2.2, 3.9 <.0001*
Cough 268 (86) 3264 (64) <.0001* 2.7 1.9, 3.9 <.0001*
Runny nose 281 (91) 4588 (89) .48
Difficulty breathing 123 (40) 1567 (31) .0007*
Sore throat 262 (85) 3912 (76) .0008*

N = 5444 illness episodes.

*

Significant at ɑ = .05.

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; PRIME, Pregnancy and Influenza Multinational Epidemiologic.

a

All models include the following covariates: country, continuous age in years, influenza vaccination status for the current season defined as verified receipt of influenza vaccine at least 14 days prior to report of symptom onset, categorical education, dichotomous underlying chronic condition, time between symptom onset and swab collection, and interaction terms for country and education and country and vaccination.